Did Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Really Improve the Survival of Patients with Hepatocellular Carcinoma?

Gastroenterology. 2020 May;158(6):1843-1844. doi: 10.1053/j.gastro.2020.01.019. Epub 2020 Jan 15.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents*
  • Carcinoma, Hepatocellular*
  • Hepacivirus
  • Hepatitis C, Chronic*
  • Humans
  • Liver Neoplasms*

Substances

  • Antiviral Agents